Financial Disclosures

Celgene provides support to a range of organisations and initiatives that make a positive impact on our patients, our communities and our world, today and for years to come. We are committed to improving the lives of patients and focus our support in areas where we can make the greatest impact.

Support for Patient Groups
In 2016, Celgene provided support to, or on behalf of, the following patient groups in the UK:

ACLT – AFRICAN CARIBBEAN LEUKAEMIA TRUST

  • Support to inform and improve disease awareness resources for patients with blood cancers and those who require blood and bone marrow transfusions and transplants – £15,000

ARTHRITIS CARE

  • Grant to Arthritis Care to provide to patients a factsheet with information about psoriatic arthritis and how patients can better manage their condition. The factsheet will be distributed at point of diagnosis and will be available to download from the Arthritis Care website – £2,500

BREAST CANCER CARE

  • Charity – matching the amount raised by Celgene employees in 2015 – £1,250

CANCER 52

  • Grant to Cancer 52 to enable investment in its website to enable patients better signposting to member charities and their information streams, support groups and clinical nurse specialists in their fields – £15,000

EUROPACOLON UK

  • Grant to support the development of the pancreatic and stomach cancer patient groups 2016 including; Maintenance of website, Webinar costs and working with groups, attending meetings and platform support – €7,000

BLOODWISE (FORMERLY LEUKAEMIA & LYMPHOMA RESEARCH)

  • Charity – matching the amount raised by Celgene employees in 2015 – £1,250

LEUKAEMIA CARE

  • Funding towards Leukaemia CARE’s Patient support services 2015 – £15,000
  • Charity – matching the amount raised by Celgene employees in 2015 – £1,250
  • Grant towards Leukaemia CARE’s 2016 Patient Education and Information, including 24-hour CARE line, Nurse Advisor, Patient Information Booklets and Patient and Carer Conferences – £15,000

LYMPHOMA ASSOCIATION

  • Unrestricted grant towards core information and support services for people affected by lymphatic cancer – £13,000
  • Consultancy fees paid in respect of reviewing patient information leaflet for MEDI-NHL-001 study – £240
  • Support towards two-day educational course titled ‘Lymphoma Management’ held on 18-19th July 2016 at Keble College at University of Oxford – £1,000

MYELOMA UK

  • Celgene contribution to 2016 Charity Bike Ride from London to Paris for 2 employees – £1,898
  • Celgene contribution to 2017 Charity Bike Ride from London to Paris for 12 employees – £11,388
  • Charity – matching the amount raised by Celgene employees in 2015 – £1,250
  • Fee paid for presentation at Myeloma Nurse Academy on 15-16th June 2016 at the Doubletree by Hilton, Nottingham – £300
  • Celgene contribution towards Myeloma UK’s support to patients and families living with Multiple Myeloma 2016 – £110,000
  • Support of Myeloma UK European patient group liaison programme – £5,000

NATIONAL RHEUMATOID ARTHRITIS SOCIETY

  • Charity – matching the amount raised by Celgene employees in 2015 – £1,250

PANCREATIC CANCER ACTION

  • Charity – matching the amount raised by Celgene employees in 2015 – £1,250

PANCREATIC CANCER UK

  • Charity – matching the amount raised by Celgene employees in 2015 – £1,250
  • Support for activities relating to disease awareness and patient/carer support 2015 – £30,000

PSORIASIS ASSOCIATION

  • Psoriasis Association Corporate Membership 2016 – £1,500
  • Charity – matching the amount raised by Celgene employees in 2015 – £1,250

RARER CANCER’S FOUNDATION

  • Grant towards Industry Reference Group 2015 – £14,000

UK MDS FORUM

  • Sponsorship of the UK MDS Forum Education Day, Thursday 17th November 2016 – £5,000

UK MDS PATIENT SUPPORT GROUP

  • Charity – matching the amount raised by Celgene employees in 2015 – £1,250

WORLD CHILD CANCER

  • 2015 donation to World Child Cancer – £48,447
  • 2016 donation to World Child Cancer – £41,466.60
  • Charity – matching the amount raised by Celgene employees in 2015 – £1,250

 
Financial disclosures for 2015
Financial disclosures for 2014
Financial disclosures for 2013
Financial disclosures for 2012


UK-CELG170076
Date of preparation: March 2017